Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC-Authored Genomics and Precision Health Publications Database|Home|PHGKB

CDC-Authored Genomics and Precision Health Publications Database


Last data update: May 20, 2022. (Total: 3839 publications since 2011)
   dataset
Filtered By:
Records 1-10 (of 10 Records)
Query Trace: all>>Jennifer L Konopka-Anstadt[CDC Author]
Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children.
Rahnuma Wahid, Laina Mercer, Chris Gast, Tirza De Leon, Xavier Sáez-Llorens, Alan Fix, Andrew MacAdam, Laura Stephens, Konstantin Chumakov, Saskia L Smits, Marta Murreddu, Jennifer L Konopka-Anstadt, M Steven Oberste, Cara C Burns, Raul Andino, Novilia Sjafri Bachtiar, Erman Tritama, Ananda S Bandyopadhyay, Gabriela Aguirre, Ricardo Rüttimann, and John O Konz
NPJ vaccines 2022 7(1) 19
Fecal shedding of two novel live attenuated oral poliovirus type 2 vaccines candidates by healthy bOPV/IPV-vaccinated infants: two randomized clinical trials.
Christopher Gast, Ananda S Bandyopadhyay, Xavier Sáez-Llorens, Tirza De Leon, Rodrigo DeAntonio, Jose Jimeno, Gabriela Aguirre, Larin M McDuffie, Elizabeth Coffee, Demetrius L Mathis, M Steven Oberste, William C Weldon, Jennifer L Konopka-Anstadt, John Modlin, Novilia S Bachtiar, Alan Fix, John Konz, Ralf Clemens, Sue Ann Costa Clemens, and Ricardo Rüttimann
The Journal of infectious diseases 2021
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses.
Rahnuma Wahid, Laina Mercer, Andrew MacAdam, Sarah Carlyle, Laura Stephens, Javier Martin, Konstantin Chumakov, Majid Laassri, Svetlana Petrovskaya, Saskia L Smits, Koert J Stittelaar, Chris Gast, William C Weldon, Jennifer L Konopka-Anstadt, M Steven Oberste, Pierre Van Damme, Ilse De Coster, Ricardo Rüttimann, Ananda Bandyopadhyay, and John Konz
NPJ vaccines 2021 6(1) 94
Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization.
Jennifer L Konopka-Anstadt, Ray Campagnoli, Annelet Vincent, Jing Shaw, Ling Wei, Nhien T Wynn, Shane E Smithee, Erika Bujaki, Ming Te Yeh, Majid Laassri, Tatiana Zagorodnyaya, Amy J Weiner, Konstantin Chumakov, Raul Andino, Andrew MacAdam, Olen Kew, and Cara C Burns
NPJ vaccines 2020 Mar 5(1) 26
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.
Ilse De Coster, Isabel Leroux-Roels, Ananda S Bandyopadhyay, Christopher Gast, Kanchanamala Withanage, Katie Steenackers, Philippe De Smedt, Annelies Aerssens, Geert Leroux-Roels, M Steven Oberste, Jennifer L Konopka-Anstadt, William C Weldon, Alan Fix, John Konz, Rahnuma Wahid, John Modlin, Ralf Clemens, Sue Ann Costa Clemens, Novilia S Bachtiar, and Pierre Van Damme
Lancet (London, England) 2020 Dec
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials.
Xavier Sáez-Llorens, Ananda S Bandyopadhyay, Christopher Gast, Tirza De Leon, Rodrigo DeAntonio, Jose Jimeno, Maria Isabel Caballero, Gabriela Aguirre, M Steven Oberste, William C Weldon, Jennifer L Konopka-Anstadt, John Modlin, Novilia S Bachtiar, Alan Fix, John Konz, Ralf Clemens, Sue Ann Costa Clemens, and Ricardo Rüttimann
Lancet (London, England) 2020 Dec
Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain.
Dominika A Kalkowska, Mark A Pallansch, Amanda Wilkinson, Ananda S Bandyopadhyay, Jennifer L Konopka-Anstadt, Cara C Burns, M Steven Oberste, Steven G F Wassilak, Kamran Badizadegan, and Kimberly M Thompson
Risk analysis : an official publication of the Society for Risk Analysis 2020 Nov
Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization.
Jennifer L Konopka-Anstadt, Ray Campagnoli, Annelet Vincent, Jing Shaw, Ling Wei, Nhien T Wynn, Shane E Smithee, Erika Bujaki, Ming Te Yeh, Majid Laassri, Tatiana Zagorodnyaya, Amy J Weiner, Konstantin Chumakov, Raul Andino, Andrew MacAdam, Olen Kew, and Cara C Burns
NPJ vaccines 2020 26
Pan-viral serology implicates enteroviruses in acute flaccid myelitis.
Ryan D Schubert, Isobel A Hawes, Prashanth S Ramachandran, Akshaya Ramesh, Emily D Crawford, John E Pak, Wesley Wu, Carly K Cheung, Brian D O'Donovan, Cristina M Tato, Amy Lyden, Michelle Tan, Rene Sit, Gavin A Sowa, Hannah A Sample, Kelsey C Zorn, Debarko Banerji, Lillian M Khan, Riley Bove, Stephen L Hauser, Amy A Gelfand, Bethany L Johnson-Kerner, Kendall Nash, Kalpathy S Krishnamoorthy, Tanuja Chitnis, Joy Z Ding, Hugh J McMillan, Charles Y Chiu, Benjamin Briggs, Carol A Glaser, Cynthia Yen, Victoria Chu, Debra A Wadford, Samuel R Dominguez, Terry Fei Fan Ng, Rachel L Marine, Adriana S Lopez, W Allan Nix, Ariane Soldatos, Mark P Gorman, Leslie Benson, Kevin Messacar, Jennifer L Konopka-Anstadt, M Steven Oberste, Joseph L DeRisi, and Michael R Wilson
Nature medicine 2019 Oct
Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis.
Nischay Mishra, Terry Fei Fan Ng, Rachel L Marine, Komal Jain, James Ng, Riddhi Thakkar, Adrian Caciula, Adam Price, Joel A Garcia, Jane C Burns, Kiran T Thakur, Kimbell L Hetzler, Janell A Routh, Jennifer L Konopka-Anstadt, W Allan Nix, Rafal Tokarz, Thomas Briese, M Steven Oberste, and W Ian Lipkin
mBio 2019 Aug (4)
TOP